Evidence map›Paper›PMID 37817548›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Race, community disadvantage, and cognitive decline: Findings from KHANDLE and STAR.

Rachel L Peterson, Rebecca Pejak, Kristen M George, Paola Gilsanz, Michelle Ko, Oanh L Meyer, Elizabeth Rose Mayeda, Amy Kind, Rachel A Whitmer

Open access · hybridAbstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Neuropathology in a diverse cohort of oldest-old: The LifeAfter90 study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  2. Article
  3. Article
  4. Neighborhood-level socioeconomic disadvantage is associated with multiple cognitive domains in a community sample of older adults.Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition · 2025
    Article
  5. Article
  6. Article
  7. Race, community disadvantage, and cognitive decline: Findings from KHANDLE and STAR.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Rachel L PetersonSchool of Public and Community Health Sciences, University of Montana, Missoula, Montana, USA.ORCID 0000-0001-6818-7009
Rebecca PejakSchool of Public and Community Health Sciences, University of Montana, Missoula, Montana, USA.
Kristen M GeorgeDepartment of Public Health Sciences, University of California Davis, Davis, California, USA.
Paola GilsanzDivision of Research, Kaiser Permanente Northern California, Oakland, California, USA.
Michelle KoDepartment of Public Health Sciences, University of California Davis, Davis, California, USA.
Oanh L MeyerDepartment of Neurology, University of California Davis, Davis, California, USA.
Elizabeth Rose MayedaFielding School of Public Health, University of California Los Angeles, Los Angeles, California, USA.
Amy KindUniversity of Wisconsin Center for Health Disparities Research, Madison, Wisconsin, USA.
Rachel A WhitmerDepartments of Public Health Sciences and Neurology, University of California Davis, Davis, California, USA.
University of California, Davis · USUniversity of Montana · USKaiser Permanente · USUniversity of California, Los Angeles · USUniversity of Wisconsin Health · US

Funding

The Neighborhoods Study: Contextual Disadvantage and Alzheimer’s Disease and Related Dementias (ADRD)R01AG070883 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI AMY J. KIND · 2021 to 2026
$42.1M
Epidemiology of Age-related Dementia, Mild Cognitive Impairment and Brain Pathology in Cohort of Oldest-OldR01AG056519 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Maria Corrada, Paola Gilsanz · 2022 to 2026
$25.8M
UC Davis Alzheimer's Disease Research CenterP30AG072972 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Charles DeCarli, Rachel A Whitmer · 2021 to 2026
$25.2M
Study of Healthy Aging in African AmericansR01AG050782 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Paola Gilsanz, Rachel A Whitmer · 2023 to 2026
$19.1M
Lifecourse health, cerebral pathology and ethnic disparities in dementia (KHANDLE Study)R01AG052132 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI GILSANZ, PAOLA, GLYMOUR, MEDELLENA MARIA · 2021 to 2025
$18.0M
Vietnamese Insights into Cognitive Aging Program (VIP)R01AG067541 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI OANH L MEYER · 2021 to 2026
$10.2M
Scientific and Technical CoreP2CHD041022 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Martha Jane Bailey · 2016 to 2026
$6.9M
Early Vascular Contributions to Dementia Risk in African-AmericansRF1AG050782 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI WHITMER, RACHEL A · 2017 to 2017
$3.8M
Neighborhood Socioeconomic Contextual Disadvantage and Alzheimer's DiseaseRF1AG057784 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI BENDLIN, BARBARA BRIGITTA, KIND, AMY J. · 2017 to 2017
$3.8M
Historical social and environmental determinants of memory decline and dementia among U.S. older adults.R01AG074359 · NIA · UNIVERSITY OF WASHINGTON · PI CASEY, JOAN A, MAYEDA, ELIZABETH ROSE · 2021 to 2025
$3.0M
Neighborhood Socioeconomic Disadvantage and Medicare's 30-Day Rehospitalization Policy: Eliminating Rehospitalization Disparities by Informing Policy Design and ImplementationR01MD010243 · NIMHD · UNIVERSITY OF WISCONSIN-MADISON · PI KIND, AMY J. · 2015 to 2019
$2.8M
Lifecourse exposure to community violence and risk of cognitive decline, Alzheimer's Disease, and related dementias among African-AmericansR01AG067525 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KO, MICHELLE JASSMINE · 2020 to 2024
$2.3M
NIA NIH HHS P30 AG072972NIA NIH HHS R00 AG073457NIA NIH HHS R01 AG050782NIA NIH HHS R01 AG052132NIA NIH HHS R01 AG056519NIA NIH HHS R01 AG067525NIA NIH HHS R01 AG067541NIA NIH HHS R01 AG070883NIA NIH HHS R01 AG074359NIA NIH HHS RF1 AG050782NIA NIH HHS RF1 AG057784NICHD NIH HHS P2C HD041022NIMHD NIH HHS R01 MD010243
6 · The paper itself

Abstract

introductionCommunity disadvantage is associated with late-life cognition. Few studies examine its contribution to racial disparities in cognition/cognitive change.

methodsInverse probability weighted models estimated expected mean differences in cognition/cognitive change attributed to residing in less advantaged communities, defined as cohort top quintile of Area Deprivation Indices (ADI): childhood 66-100; adulthood ADI 5-99). Interactions by race tested.

resultsMore Black participants resided in less advantaged communities. Semantic memory would be lower if all participants had resided in less advantaged childhood (b = -0.16, 95% confidence interval [CI] = -0.30, -0.03) or adulthood (b = -0.14, 95% CI = -0.22, -0.04) communities. Race interactions indicated that, among Black participants, less advantaged childhood communities were associated with higher verbal episodic memory (interaction p-value = 0.007) and less advantaged adulthood communities were associated with lower semantic memory (interaction p-value = 0.002). DISCUSSION: Examining racial differences in levels of community advantage and late-life cognitive decline is a critical step toward unpacking community effects on cognitive disparities.

Indexed as

Cognitive DysfunctionMemory, EpisodicAdultBlack or African AmericanChildCognitionHumansNeighborhood CharacteristicsSocial DeprivationSocial Determinants of Healthhealth disparitiessocial determinantssocial epidemiologystructural racism

Identifiers

PMID37817548
PMCPMC10917037
OpenAlexW4387515735

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.